HPC
NUVA

HM Payson & Co’s NuVasive, Inc. NUVA Stock Holding History

HM Payson & Co’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-50
Closed -$3K – 1192
2021
Q3 		$3K Hold
50
– – ﹤0.01% 978
2021
Q2 		$3K Hold
50
– – ﹤0.01% 972
2021
Q1 		$3K Hold
50
– – ﹤0.01% 1023
2020
Q4 		$3K Buy
+50
New +$2.46K ﹤0.01% 995

Other funds holding NUVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

HM Payson & Co's NUVA Position: Q4 2021 in Review

HM Payson & Co sold out of NuVasive, Inc. (NUVA) in Q4 2021, closing a stake of 50 shares — an estimated $3K sold.

HM Payson & Co first reported a position in NUVA in Q4 2020 and held it in 4 quarters. The position peaked at $3K in Q3 2021. 249 funds tracked by Wall St. Rank hold NUVA as of Q4 2021.

  • HM Payson & Co reported no remaining NuVasive, Inc. position as of Q4 2021 after selling out during the quarter.
  • HM Payson & Co sold 50 NuVasive, Inc. shares in Q4 2021, an estimated $3K.
  • HM Payson & Co first reported a position in NuVasive, Inc. in Q4 2020 and held it in 4 quarters.
  • HM Payson & Co's NuVasive, Inc. position peaked at $3K in Q3 2021.
  • 249 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q4 2021.

Based on HM Payson & Co's 13F filing for Q4 2021, filed 15 Feb 2022.